New Leadership and Focus on Advancement of IkT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial ...

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

Starboard Value on Wednesday nominated three director candidates, including its chief executive and founder, Jeff Smith, to ...

Marc Forth Steps Down as President and CEO to Pursue Another Opportunity; will remain on the Board of Directors –– Jost Fischer, Chairman of ...

Lyndra Therapeutics, a drug developer that spun out of the lab of MIT professor Bob Langer in 2015, is winding down ...

Novo is paying up to $1 billion for a “non-incretin” medicine that might boost Wegovy’s effects. Elsewhere, Arbutus laid off ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing Abelson Tyrosine Kinase inhibitor therapeutics for Cardiopulmonary disease. Inhibikase's ...

Jong-Hee Han, 63 years old, was appointed co-CEO of Samsung Electronics in December 2021. The company’s other CEO, Jun Young-hyun, oversaw the unit making semiconductors and other tech components.

Investing.com -- AstraZeneca (NASDAQ:AZN) Plc’s Chief Executive Officer, Pascal Soriot, has warned that Europe is rapidly losing its pharmaceutical innovation edge to China. He voiced his concerns ...

Venture Global, whose $58 billion market debut fell short of high expectations in January, began generating proceeds in 2022 with its Calcasieu Pass facility. Sawan during Shell's capital markets ...

Samsung Electronics co-CEO Han Jong-Hee died from cardiac arrest on Tuesday, according to a spokesperson for the South Korean tech giant. Han was 63. Born in 1962, Han had overseen Samsung’s ...